CERo Therapeutics Holdings, Inc entered into a purchase agreement with Arena Business Solutions Global SPC II, Ltd, pursuant to the agreement the company has agreed to issue common stock for proceeds of $25 million on February 23, 2024.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.18 USD | +1.72% | -9.23% | -89.27% |
02/04 | CERo Therapeutics Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
11/03 | Top Premarket Decliners | MT |
1st Jan change | Capi. | |
---|---|---|
-89.27% | 17.08M | |
+3.87% | 111B | |
+11.52% | 105B | |
-12.59% | 22.34B | |
-3.70% | 21.93B | |
-6.03% | 18.59B | |
-35.21% | 18.12B | |
-10.67% | 16.96B | |
+2.90% | 13.7B | |
+36.91% | 12.45B |
- Stock Market
- Equities
- CERO Stock
- News CERo Therapeutics Holdings, Inc.
- CERo Therapeutics Holdings, Inc. announced that it expects to receive $25 million in funding from Arena Business Solutions Global SPC II, Ltd.